Literature DB >> 35351586

[11C]NCGG401, a novel PET ligand for imaging of colony stimulating factor 1 receptors.

Aya Ogata1, Bin Ji2, Takashi Yamada3, Saori Hattori3, Junichiro Abe3, Hiroshi Ikenuma3, Masanori Ichise4, Hiroko Koyama5, Masaaki Suzuki3, Takashi Kato3, Kengo Ito3, Yasuyuki Kimura6.   

Abstract

Colony-stimulating factor 1 receptors (CSF1R) are expressed exclusively on microglia in the central nervous system. The receptors regulate immune responses by controlling the survival and activity of microglia and are intricately involved in the pathophysiology of Alzheimer's disease. In this study, we developed [11C]NCGG401, a positron emission tomography (PET) ligand, targeting for CSF1R as an imaging biomarker for microglial pathophysiology in Alzheimer's disease. NCGG401 showed a high potency to inhibit human CSF1R kinase activity and a high binding affinity to human CSF1R. PET imaging with [11C]NCGG401 in healthy rats showed a good brain permeability. Furthermore, the specific binding component was determined by postmortem autoradiography in rat brain and human hippocampal sections. The knowledge of the characteristics of [11C]NCCC401, our initial CSF1R compound, we have obtained may be useful for further development and optimization of CSF1R radioligands for PET imaging of microglia.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Colony-stimulating factor 1 receptor; Microglia; Positron emission tomography

Mesh:

Substances:

Year:  2022        PMID: 35351586     DOI: 10.1016/j.bmcl.2022.128704

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor.

Authors:  Jennifer M Coughlin; Yong Du; Wojciech G Lesniak; Courtney K Harrington; Mary Katherine Brosnan; Riley O'Toole; Adeline Zandi; Shannon Eileen Sweeney; Rehab Abdallah; Yunkou Wu; Daniel P Holt; Andrew W Hall; Robert F Dannals; Lilja Solnes; Andrew G Horti; Martin G Pomper
Journal:  EJNMMI Res       Date:  2022-09-30       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.